Navigating the Shadows: COVID-19 ′s Lingering Threat – Pulmonary Fibrosis

Pulmonary fibrosis has long been associated with significant morbidity. Yet, the precise relationship between coronavirus disease 2019 (COVID-19) and this debilitating condition has remained relatively uncharted territory. A study by Najjar-Debbiny et al1 followed a cohort of 2,894,801 adults for the occurrence of pulmonary fibrosis from May 1, 2020, to June 30, 2022. Individuals who had experienced COVID-19 were found to have an increased risk of pulmonary fibrosis, with an odds ratio of 1.80 compared with those who had not contracted the virus.
Source: The American Journal of Medicine - Category: General Medicine Authors: Tags: Letter Source Type: research